Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

ING200336: A Prospective, Interventional Pharmacokinetic and Safety Study of DTG/ABC/3TC in Pregnant Women

NCT02075593 is registered in ClinicalTrials.gov with ViiV Healthcare as lead sponsor.

NCT NCT02075593
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02075593 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
ING200336: A Prospective, Interventional Pharmacokinetic and Safety Study of DTG/ABC/3TC in Pregnant Women
Lead sponsor
ViiV Healthcare
Phase
Phase 3
Overall status
Completed
Start date
December 17, 2014
Completion date
September 15, 2021
Enrollment
4 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

arthralgia, hiv infections, infection, human immunodeficiency virus